Would you use SBRT in patients with medically inoperable renal cell carcinoma?

Yes. Together with Drs. @Dr. First Last and Lee Ponsky from University Hospitals Seidman Cancer Center (UHSCC), we have published the first North American trial of SBRT for medically inoperable renal cell carcinoma. The attempt to escalate the dose from 24 Gy in 4 fxs to 48 Gy in 4 fxs was successfu...

Agree with all the above. Even thinking of moving towards small renal masses suitable for ablation or high risk partial nephrectomy. We just completed a pilot RCT in Canada of SBRT (25 Gy/1) vs RFA (NCT03811665). Very well tolerated! No need for fiducials if using Linac based SBRT with daily CBCT. A...